151 related articles for article (PubMed ID: 18171015)
1. Understanding tubulin/microtubule-taxane interactions: a quantitative structure-activity relationship study.
Hansch C; Verma RP
Mol Pharm; 2008; 5(1):151-61. PubMed ID: 18171015
[TBL] [Abstract][Full Text] [Related]
2. Overcoming tumor drug resistance with C2-modified 10-deacetyl-7-propionyl cephalomannines: a QSAR study.
Hansch C; Verma RP
Mol Pharm; 2009; 6(3):849-60. PubMed ID: 19334723
[TBL] [Abstract][Full Text] [Related]
3. Taxane analogues against breast cancer: a quantitative structure-activity relationship study.
Verma RP; Hansch C
ChemMedChem; 2008 Apr; 3(4):642-52. PubMed ID: 18196507
[TBL] [Abstract][Full Text] [Related]
4. Taxane analogues against lung cancer: a quantitative structure-activity relationship study.
Verma RP; Hansch C
Chem Biol Drug Des; 2009 Jun; 73(6):627-36. PubMed ID: 19635054
[TBL] [Abstract][Full Text] [Related]
5. 3D QSAR models of interactions between beta-tubulin and microtubule stabilizing antimitotic agents (MSAA): a survey on taxanes and epothilones.
Manetti F; Maccari L; Corelli F; Botta M
Curr Top Med Chem; 2004; 4(2):203-17. PubMed ID: 14754454
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanism of action of microtubule-stabilizing anticancer agents.
Prota AE; Bargsten K; Zurwerra D; Field JJ; Díaz JF; Altmann KH; Steinmetz MO
Science; 2013 Feb; 339(6119):587-90. PubMed ID: 23287720
[TBL] [Abstract][Full Text] [Related]
7. Relationship between the structures of taxane derivatives and their microtubule polymerization activity.
Hidaka M; Koga T; Kiyota H; Horiguchi T; Shi QW; Hirose K; Uchida T
Biosci Biotechnol Biochem; 2012; 76(2):349-52. PubMed ID: 22313785
[TBL] [Abstract][Full Text] [Related]
8. Taxanes with high potency inducing tubulin assembly overcome tumoural cell resistances.
Matesanz R; Trigili C; Rodríguez-Salarichs J; Zanardi I; Pera B; Nogales A; Fang WS; Jímenez-Barbero J; Canales A; Barasoain I; Ojima I; Díaz JF
Bioorg Med Chem; 2014 Sep; 22(18):5078-90. PubMed ID: 25047938
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship of taxol inferring from docking taxol analogues to microtubule binding site.
Xiang F; Yu J; Yin R; Ma Y; Yu L
Z Naturforsch C J Biosci; 2009; 64(7-8):551-6. PubMed ID: 19791508
[TBL] [Abstract][Full Text] [Related]
10. Insights into the interaction of discodermolide and docetaxel with tubulin. Mapping the binding sites of microtubule-stabilizing agents by using an integrated NMR and computational approach.
Canales A; Rodríguez-Salarichs J; Trigili C; Nieto L; Coderch C; Andreu JM; Paterson I; Jiménez-Barbero J; Díaz JF
ACS Chem Biol; 2011 Aug; 6(8):789-99. PubMed ID: 21539341
[TBL] [Abstract][Full Text] [Related]
11. QSAR modeling of taxane analogues against colon cancer.
Verma RP; Hansch C
Eur J Med Chem; 2010 Apr; 45(4):1470-7. PubMed ID: 20116905
[TBL] [Abstract][Full Text] [Related]
12. Structural Basis of Microtubule Stabilization by Discodermolide.
Prota AE; Bargsten K; Redondo-Horcajo M; Smith AB; Yang CH; McDaid HM; Paterson I; Horwitz SB; Fernando Díaz J; Steinmetz MO
Chembiochem; 2017 May; 18(10):905-909. PubMed ID: 28207984
[TBL] [Abstract][Full Text] [Related]
13. Zampanolide, a potent new microtubule-stabilizing agent, covalently reacts with the taxane luminal site in tubulin α,β-heterodimers and microtubules.
Field JJ; Pera B; Calvo E; Canales A; Zurwerra D; Trigili C; Rodríguez-Salarichs J; Matesanz R; Kanakkanthara A; Wakefield SJ; Singh AJ; Jiménez-Barbero J; Northcote P; Miller JH; López JA; Hamel E; Barasoain I; Altmann KH; Díaz JF
Chem Biol; 2012 Jun; 19(6):686-98. PubMed ID: 22726683
[TBL] [Abstract][Full Text] [Related]
14. Elucidating the mechanism of action of the clinically approved taxanes: a comprehensive comparison of local and allosteric effects.
Churchill CD; Klobukowski M; Tuszynski JA
Chem Biol Drug Des; 2015 Nov; 86(5):1253-66. PubMed ID: 26032329
[TBL] [Abstract][Full Text] [Related]
15. Pocket similarity identifies selective estrogen receptor modulators as microtubule modulators at the taxane site.
Lo YC; Cormier O; Liu T; Nettles KW; Katzenellenbogen JA; Stearns T; Altman RB
Nat Commun; 2019 Mar; 10(1):1033. PubMed ID: 30833575
[TBL] [Abstract][Full Text] [Related]
16. Differences in paclitaxel and docetaxel interactions with tubulin detected by mutagenesis of yeast tubulin.
Winefield RD; Entwistle RA; Foland TB; Lushington GH; Himes RH
ChemMedChem; 2008 Dec; 3(12):1844-7. PubMed ID: 18988212
[No Abstract] [Full Text] [Related]
17. βIII-tubulin enhances efficacy of cabazitaxel as compared with docetaxel.
Smiyun G; Azarenko O; Miller H; Rifkind A; LaPointe NE; Wilson L; Jordan MA
Cancer Chemother Pharmacol; 2017 Jul; 80(1):151-164. PubMed ID: 28567478
[TBL] [Abstract][Full Text] [Related]
18. Zampanolide and dactylolide: cytotoxic tubulin-assembly agents and promising anticancer leads.
Chen QH; Kingston DG
Nat Prod Rep; 2014 Sep; 31(9):1202-26. PubMed ID: 24945566
[TBL] [Abstract][Full Text] [Related]
19. Dissecting paclitaxel-microtubule association: quantitative assessment of the 2'-OH group.
Sharma S; Lagisetti C; Poliks B; Coates RM; Kingston DG; Bane S
Biochemistry; 2013 Apr; 52(13):2328-36. PubMed ID: 23473345
[TBL] [Abstract][Full Text] [Related]
20. Structural insight into the stabilization of microtubules by taxanes.
Prota AE; Lucena-Agell D; Ma Y; Estevez-Gallego J; Li S; Bargsten K; Josa-Prado F; Altmann KH; Gaillard N; Kamimura S; Mühlethaler T; Gago F; Oliva MA; Steinmetz MO; Fang WS; Díaz JF
Elife; 2023 Mar; 12():. PubMed ID: 36876916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]